GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » SynCore Biotechnology Co Ltd (ROCO:4192) » Definitions » Shiller PE Ratio

SynCore Biotechnology Co (ROCO:4192) Shiller PE Ratio : (As of May. 24, 2024)


View and export this data going back to 2014. Start your Free Trial

What is SynCore Biotechnology Co Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


SynCore Biotechnology Co Shiller PE Ratio Historical Data

The historical data trend for SynCore Biotechnology Co's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SynCore Biotechnology Co Shiller PE Ratio Chart

SynCore Biotechnology Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

SynCore Biotechnology Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of SynCore Biotechnology Co's Shiller PE Ratio

For the Biotechnology subindustry, SynCore Biotechnology Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SynCore Biotechnology Co's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, SynCore Biotechnology Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where SynCore Biotechnology Co's Shiller PE Ratio falls into.



SynCore Biotechnology Co Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

SynCore Biotechnology Co's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, SynCore Biotechnology Co's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.38/131.7762*131.7762
=-0.380

Current CPI (Mar. 2024) = 131.7762.

SynCore Biotechnology Co Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 -4.396 100.560 -5.761
201409 -5.055 100.428 -6.633
201412 -4.204 99.070 -5.592
201503 -3.260 99.621 -4.312
201506 -2.564 100.684 -3.356
201509 -4.495 100.392 -5.900
201512 -1.145 99.792 -1.512
201603 -3.095 100.470 -4.059
201606 -3.943 101.688 -5.110
201609 -3.390 101.861 -4.386
201612 0.231 101.863 0.299
201703 -3.316 102.862 -4.248
201706 -3.316 103.349 -4.228
201709 -3.390 104.136 -4.290
201712 -3.574 104.011 -4.528
201803 -2.727 105.290 -3.413
201806 -3.648 106.317 -4.522
201809 -3.758 106.507 -4.650
201812 -4.164 105.998 -5.177
201903 -2.800 107.251 -3.440
201906 -5.380 108.070 -6.560
201909 -4.495 108.329 -5.468
201912 -4.274 108.420 -5.195
202003 -3.206 108.902 -3.879
202006 -3.979 108.767 -4.821
202009 -3.537 109.815 -4.244
202012 -3.549 109.897 -4.256
202103 -2.395 111.754 -2.824
202106 -2.837 114.631 -3.261
202109 -7.001 115.734 -7.971
202112 -2.579 117.630 -2.889
202203 -1.363 121.301 -1.481
202206 -1.083 125.017 -1.142
202209 -0.984 125.227 -1.035
202212 -2.714 125.222 -2.856
202303 -0.780 127.348 -0.807
202306 -0.847 128.729 -0.867
202309 -0.945 129.860 -0.959
202312 1.184 129.419 1.206
202403 -0.380 131.776 -0.380

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


SynCore Biotechnology Co  (ROCO:4192) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


SynCore Biotechnology Co Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of SynCore Biotechnology Co's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


SynCore Biotechnology Co (ROCO:4192) Business Description

Traded in Other Exchanges
N/A
Address
No.84 Zhongshan Road, Zhongshan Village, Dongshan Township, Yilan, TWN, 269
SynCore Biotechnology Co Ltd is a biopharmaceutical company. Its pipeline products concentrate on the ophthalmology, oncology, and dermatology fields. The pipeline products of the company include SB01 and 02, SB03, SB04, and SB05. It is engaged in drug development and sale, food advisory, medicine inspection, biotechnology service and intellectual property. It operates in a single industry, the new drug development.

SynCore Biotechnology Co (ROCO:4192) Headlines

No Headlines